Thanks TT. So, if TGA is circa one year from submission then the decision will be roughly either at the end of Q1 2021 (that would be around 9 months from the submission date being July 2020). Or if it’s closer to a year then it would be end of Q2 in 2021.
Either way, there could still be a fair bit of time to wait for TGA.
US FDA for bile duct looks like similar timeline as well. We can forget 2020 now. So, Q1 2021 would be up to March for that approval as well. If later then it slips into Q2 in 2021.
No sales in Europe in 2020. So, again at best some modest sales in Q1 in 2021 or maybe more likely Q2 in 2021.
No appointed CEO until either Q1 in 2021 or again Q2 in 2021.
Would these timelines be about right?
Thanks TT. So, if TGA is circa one year from submission then the...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $191.9K | 21.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 8525000 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 964494 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |